4//SEC Filing
Svoronos Dawn 4
Accession 0000950170-23-026178
CIK 0001582313other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:24 PM ET
Size
5.2 KB
Accession
0000950170-23-026178
Insider Transaction Report
Form 4
Graham Dawn
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-02+18,475→ 18,475 totalExercise: $38.96Exp: 2033-06-01→ Common Shares (18,475 underlying)
Footnotes (1)
- [F1]Vesting 100% on the earlier of (i) June 1, 2024 or (ii) the day immediately preceding the day of the following year's annual meeting.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001574579
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 5:24 PM ET
- Size
- 5.2 KB